269
Views
0
CrossRef citations to date
0
Altmetric
Editorial

HIV Pol: does it offer therapeutic targets for HIV?

&
Pages 341-343 | Received 13 Dec 2023, Accepted 01 May 2024, Published online: 09 May 2024
 

Article highlights

  • Advances in knowledge of the structure of HIV Pol may contribute to the development of antiretroviral strategies.

  • The dimerization of reverse transcriptase has a profound effect on the maturation of HIV pol precursors.

  • An approach targeting CARD8 inflammasome activation combined with a ‘shock and kill’ scheme may be explored for an HIV cure trial.

  • Because Pol is a highly conserved region of the HIV genome, it can be targeted by CRISPR-Cas technology and designed for HIV vaccine.

Abbreviations

PR, protease; RT, reverse transcriptase; IN, integrase.

Declaration of interests

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript.

Reviewer disclosures

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Additional information

Funding

This paper was not funded.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.